Abstract
The variability of the products of polymerase chain reactions, due to mutations and to incomplete replications, can have important clinical consequences. Sun (1995) and Weiss and von Haeseler (1995) modeled
these errors by a branching process and introduced estimators of the mutation rate and of the efficiency of the reaction based, for example, on the empirical distribution of the mutations of a random sequence.
This distribution involves a noncanonical branching Markov chain which, although easy to describe, is not analytically tractable except in the infinite-population limit. These authors for the infinite-target
limit, and Wang
Keywords
Get full access to this article
View all access options for this article.
